COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 1 for:    NCT 03553550
Previous Study | Return to List | Next Study

Role of Circulating Tumor DNA (ctDNA) From LIquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation (LIBERTI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03553550
Recruitment Status : Terminated (Enrollment futility)
First Posted : June 12, 2018
Last Update Posted : November 19, 2020
Information provided by (Responsible Party):
Addario Lung Cancer Medical Institute

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : November 15, 2020
Actual Study Completion Date : November 15, 2020